Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

NCT00505882 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Pramlintide
DRUG: Glargine
DRUG: Lispro
DRUG: Aspart

Sponsor

University of Texas Southwestern Medical Center